Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

被引：112

作者：

Knake, S. ^{[1
]}

Gruener, J. ^{[1
]}

Hattemer, K. ^{[1
]}

Klein, K. M. ^{[1
]}

Bauer, S. ^{[1
]}

Oertel, W. H. ^{[1
]}

Hamer, H. M. ^{[1
]}

Rosenow, F. ^{[1
]}

机构：

[1] Univ Marburg, Epilepsy Ctr Marburg, Dept Neurol, D-35033 Marburg, Germany

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2008年 / 79卷 / 05期

关键词：

D O I：

10.1136/jnnp.2007.130260

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In 2006, levetiracetam was approved as the first of the newer anticonvulsive drugs as an intravenous formulation (ivLEV) for patients with epileptic seizures who are unable to take oral medication. We report our experience with the use of ivLEV for the treatment of 18 episodes of benzodiazepine refractory focal status epilepticus (SE) in 16 patients, including four patients with secondary generalised SE. SE was controlled in all patients by the given combination of drugs; application of further antiepileptic medications after ivLEV was necessary in two episodes. No severe side effects occurred. Our data suggest that ivLEV may be an alternative for the treatment of SE in the future, even in patients that did not respond to benzodiazepines. A large prospective, randomised, controlled study is warranted to investigate the efficacy and safety of ivLEV for the treatment of SE.

引用

页码：588 / 589

页数：2

共 9 条

[1]

DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316

[2] Incidence of status epilepticus in adults in Germany: A prospective, population-based study [J].

Knake, S ;

Rosenow, F ;

Vescovi, M ;

Oertel, WH ;

Mueller, HH ;

Wirbatz, A ;

Katsarou, N ;

Hamer, HM .

EPILEPSIA, 2001, 42 (06) :714-718

[3] Status epilepticus after stroke is associated with increased long-term case fatality [J].

Knake, Susanne ;

Rochon, Justine ;

Fleischer, Sarah ;

Katsarou, Niki ;

Back, Tobias ;

Vescovi, Mathias ;

Oertel, Wolfgang H. ;

Reis, Janine ;

Hamer, Hajo M. ;

Rosenow, Felix .

EPILEPSIA, 2006, 47 (12) :2020-2026

[4] The use of levetiracetam in refractory status epilepticus [J].

Patel, NC ;

Landan, IR ;

Levin, J ;

Szaflarski, J ;

Wilner, AN .

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2006, 15 (03) :137-141

[5] Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study [J].

Ramael, Steven ;

Daoust, Agnes ;

Otoul, Christian ;

Toublanc, Nathalie ;

Troenaru, Mona ;

Lu, Zhihong ;

Stockis, Armel .

EPILEPSIA, 2006, 47 (07) :1128-1135

[6] Determinants of success in the use of oral levetiracetam in status epilepticus [J].

Rossetti, Andrea O. ;

Bromfield, Edward B. .

EPILEPSY & BEHAVIOR, 2006, 8 (03) :651-654

[7] Levetiracetam as a treatment option in non-convulsive status epilepticus [J].

Rupprecht, Sven ;

Franke, Kerstin ;

Fitzek, Sabine ;

Witte, Otto W. ;

Hagemann, Georg .

EPILEPSY RESEARCH, 2007, 73 (03) :238-244

[8]

SCHULZEBONHAGE A, 2007, J NEUROL NEUROS 0312

[9] A comparison of four treatments for generalized convulsive status epilepticus [J].

Treiman, DM ;

Meyers, PD ;

Walton, NY ;

Collins, JF ;

Colling, C ;

Rowan, AJ ;

Handforth, A ;

Faught, E ;

Calabrese, VP ;

Uthman, BM ;

Ramsay, RE ;

Mamdani, MB .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :792-798

← 1 →